Fructose consumption and physical exercise, the impact on metabolic syndrome;Consumo de frutose e exercício físico, impacto na síndrome metabólica

Motriz. Revista de Educacao Fisica

Volumn 16, Issue 1, 2010, Pages 231-239

  Botezelli, José Diego ^a   De Moura, Rodrigo Ferreira ^a   De Almeida Rossi, Caroline ^a   Dalia, Rodrigo Augusto ^a   Cambri, Lucieli Teresa ^a   De Mello, Maria Alice Rostom ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Fructose consumption; Hepatic steatosis; Metabolic syndrome; Physical exercise

Indexed keywords

EID: 84855939180     PISSN: 14159805     EISSN: 19806574     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. BASCIANO, H.; FEDERICO, L.; KHOSROW, A. Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition & Metabolism, v. 2, p. 5-19, 2005. http://dx.doi.org/10.1186/1743-7075-2-5.
2. BEZERRA, R. M. N. et al. A high-fructose diet induces insulin resistance but not blood pressure changes in normotensive rats. Brazilian Journal of Medical and Biological Research, v. 34, p. 1155-1160, 2001. http://dx.doi.org/ 10.1590/S0100-879X2001000900008. (Pubitemid 33632099)
3. BRAY, G. A.; NIELSEN, S. J.; POPKIN, B. M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. American Journal of Clinical Nutrition, v. 79, p. 537-43, 2004. (Pubitemid 41103894)
4. CATENA, C. et al. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. American Journal of Hypertension, v. 16, p. 973-978, 2003. (Pubitemid 37315498)
5. CHONG, M. F. F.; FIELDING B. A.; FRAYN, K. N. Mechanisms for the acute effect of fructose on postprandial lipemia. American Journal of Clinical Nutrition, Oxford, v. 85, n. 6, p. 1511-1520, 2007. (Pubitemid 46890417)
6. CIOLAC, E. G.; GUIMARÃES, G. V. Exercício físico e síndrome metabólica. Revista Brasileira de Medicina do Esporte, v. 10, n. 4, p. 319-324, 2004.
7. CIOLAC, E. G.; GUIMARÃES, G. V. Importância do exercício resistido para o idoso. Revista da Sociedade de Cardiologia do Estado de São Paulo, v. 12, p. S15-26, 2002.
8. CLARK, J. M.; DIEHL, A. M. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. Journal of American Medicine Associate, v. 289, p. 3000-3004, 2003a. (Pubitemid 37430103)
9. CLARK, J. M.; BRANCATI, F. L.; DIEHL, A. M. The prevalence and etiology of elevated aminotransferase levels in the United States. American Journal of Gastroenterology v. 98, p. 960-967, 2003b. (Pubitemid 36733754)
10. DEL GAUDIO, A. et al. Liver damage in obese patients. Obesity Surgery, v. 12, p. 802-4, 2002. http://dx.doi.org/10.1381/096089202320995592. (Pubitemid 36135524)
11. DOMINGO, J. L.; GOMEZ M.; SANCHEZ, D. J.; LLOBET J. M.; KEEN C. L. Tiron administration minimizes the toxicity of vanadate but not its insulin mimetic properties in diabetic rats. Life Sciences v. 50, n. 18, p. 1311-1317, 1992
12. DUNCAN, B. B.; SCHIMIDT, M. A. Chronic ativation of th innate immune sistem may underlie the metabolic sindrome. São Paulo Medicine Journal, v. 119, n. 3, p. 122-7, 2001. http://dx.doi.org/10.1590/S1516-31802001000300008.
13. EBELING, P. et al. Mechanisms of enhanced insulin sensitivity in athletes: increased blood flow, muscle glucose transport protein (GLUT-4) concentration and glycogen syntase activity. Journal of Clinical Investigation, v. 92, p. 1623-31, 1993. (Pubitemid 23304523)
14. ERIKSSON, J.; TAIMELA, S.; KOIVISTO, V. A. Exercise and the metabolic syndrome. Diabetologia, v. 40, p. 125-35, 1997. http://dx.doi.org/10.1007/ s001250050653. (Pubitemid 27060283)
15. FAEH, D. et al. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes, Los Angeles, v. 54, n. 7, p. 1907-1913, 2005. http://dx.doi.org/10.2337/diabetes.54.7.1907. (Pubitemid 40911251)
16. FIELDS, M.; LEWIS, C. G., LURE, M. D. Responses of insulin to oral glucose and fructose loads in marginally copper-deficient rats fed starch or fructose. Nutrition v. 12, p. 524-8, 1996. (Pubitemid 26299994)
17. FORD, E. S.; GILES, W. H.; MOKDAD, A. H. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care, v. 27, p. 2444-49, 2004. (Pubitemid 39281399)
18. GALE, E. A. M. The myth of metabolic syndrome. Diabetologia, Bristol, v. 48, n. 9, p. 1679-1683, 2005. http://dx.doi.org/10.1007/s00125-005-1873-5.
19. GROSS, et al. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabetic Medicine, v. 21, n. 3, p. 252-255, 2004. (Pubitemid 38299619)
20. GUPTE, P. et al. Non-alcoholic steatohepatitis in type 2diabetes mellitus. Journal of Gastroenterology Hepatology, v. 19, p. 854-8, 2004. (Pubitemid 39093200)
21. HANLEY, A. J. G. et al. Liver Markers and Development of the Metabolic Syndrome. The Insulin Resistance Atherosclerosis Study. Diabetes, v. 54, p. 3140-3147, 2005. http://dx.doi.org/10.2337/diabetes.54.11.3140. (Pubitemid 43334367)
22. HICKMAN, I. J. et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin and quality of life. International Journal of Gastroenterology and Hepatology, v. 53, p. 413-419, 2004. http://dx.doi.org/10.1136/gut.2003.027581. (Pubitemid 38241340)
23. HUANG, M. H. et al. Prevalence and risk factorsof nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults. Journal of Clinical Gastroenterology, v. 40, n. 8, p. 745-752, 2006.
24. HWANG, I. S. et al. Fructose-induced insulin resistance and hypertension in rats. Hypertension, v. 10, p. 512-6, 1989.
25. IVY, J. L. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Medicine, v. 24, p. 321-36, 1997. (Pubitemid 27490263)
26. KAHN, R. et al. The metabolic syndrome: time for a critical appraisal. Diabetologia, v. 48, n. 9, p. 1679-83, 2005. http://dx.doi.org/10.2337/diacare. 29.01.06.dc05-2007.
27. KIM, J. S. et al. Hypoglycemic and anthihyperlipemic effect of four Korean medicinal plants in alloxan induced diabetic rats. American Journal of Biochemistry and Biotechnology, v. 2, p. 154-160, 2006.
28. LAKKA, T. A. et al. Sedentary life style, poor cardiorespiratory fitness, and the metabolic syndrome. Medicine Science Sports Exercise, v. 35, p. 1279-86, 2003. (Pubitemid 36936144)
29. LEE, Y. C. et al. Plasma leptin response to oral glucose tolerance and fasting/re-feeding tests in rats with fructose-induced metabolic derangements. Life Sciences, v. 78, p. 1155-1162, 2006. http://dx.doi.org/10.1016/j.lfs.2005. 06.009.
30. MARCHESINI, G. et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, v. 50, p. 1844-1850, 2001. http://dx.doi.org/10. 2337/diabetes.50.8.1844. (Pubitemid 33641605)
31. MCARDLE, W. D.; KATCH, F. I.; KATCH, V. L. Fisiologia do exercício: energia, nutrição e desempenho humano. 4a ed. Rio de Janeiro: Ed. Guanabara Koogan, 1998.
32. MELLO, M. A. R.; LUCIANO, E. Obesidade e Desnutrição In: Obesidade. 1ed. Rio de Janeiro: Medicine Science, v. 1, p. 153-169, 2003.
33. MILLER, J. P. et al. Strength training increases insulin action in healthy 50 - to 65-yr-old men. Journal of Applied Physiology, v. 77, p. 1122-7, 1994. (Pubitemid 24299361)
34. MOTA, C. S. et al. Exercise training in aerobic/anaerobic metabolic trasition prevents glucose intolerance in alloxan-treated rats. Endocrines and Disorders, v. 8, n. 11, p. 1-9, 2008. http://dx.doi.org/10.1186/1472-6823-8-11.
35. MUKAI, M. et al. Liver disorder and related physical conditions and life style. Digestive Disorders and Sciences, v. 47, p. 549-555, 2002. http://dx.doi.org/10.1023/A:1017959801493.
36. MULHALL, B. P.; ONG, J. P.; YOUNOSSI, Z. M. Non-alcoholic fatty liver disease: an overview. Journal of Gastroenterology and Hepatology, v. 17, p. 1136-1143, 2002. (Pubitemid 36015607)
37. NAGAI, Y. et al. Amelioration of high fructoseinduced metabolic derangements by activation of PPARα. American Journal of Physiology Endocrinology and Metabolism, v. 282, p. E1180-E1190, 2002. http://dx.doi.org/ 10.1152/ajpendo.00471.20010193-1849/02. (Pubitemid 34654734)
38. NUUTILA, P. et al. Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. Journal of Clinical Investigation, v. 93, p. 2267-74, 1994. http://dx.doi.org/0021-9738/94/05/2267/ 08. (Pubitemid 24143112)
39. OKADA, Y. et al. Effects of the K+ Channel Opener KRN4884 on the Cardiovascular Metabolic Syndrome Model in Rats. Journal of Cardiovascular Pharmacology, v. 35, n. 2, p. 287-293, 2000 (Pubitemid 30073822)
40. OMS, Organização Mundial de Saúde. WHO consultation: Definition, diagnosis and classification of diabetes mellitus and its cimplications. WHO/NCD/NCS/99, v. 2, p. 31-33, 1991.
41. PERSGHIN, G. et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulinresistant subjects. New England Journal of Medicine, v. 335, p. 1357-62, 1996.
42. POLLOCK, M. L. et al. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: an advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American Heart Association. Circulation, v. 101, p. 828-33, 2000. (Pubitemid 30100093)
43. QIN, B. et al. Voluntary running improves in vivo insulin resistance in high-salt diet-fed rats. Experimental Biology and Medicine, v. 232, p. 1330-1337, 2007. http://dx.doi.org/10.3181/0704-RM-107. (Pubitemid 350014423)
44. REAVEN, G. Role of insulin resistance in human disease. Diabetes, v. 37, p. 1595-1607, 1988. (Pubitemid 19004941)
45. RECTOR, R. S. et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty Rats. American Journal Physiology of Gastrointestinal and Liver Physiology, v. 294, p. g619-626, 2008. http://dx.doi.org/10.1152/ajpgi.00428.2007. (Pubitemid 351468778)
46. RODEN, M. et al. Mechanism of free fatty acidinduced insulin resistance in humans. Journal of Clinical Investigation, v. 97, p. 2859-2865, 1996. http://dx.doi.org/10.1172/JCI118742. (Pubitemid 26197099)
47. ROGERS, M. A. Acute effects of exercise on glucose tolerance in non-insulin-dependent diabetes. Medicine e Science in Sports & Exercise, v. 21, n. 4, p. 362-368, 1989. (Pubitemid 19200484)
48. RUMESSEN, J. J. Fructose and related food carbohydrates. Scandinavian Journal of Gastorenterology, v. 27, p. 819-28, 1992.
49. SAMAD, F. et al. Tumor necrosis factor alpha is a key component in the obesity - linked elevation of plasminogen activador inhibitor 1. Proceedings of National Academy of Sciences USA, v. 96, p. 6902-7, 1999. (Pubitemid 29274982)
50. SCHNEIDER, S. H.; RUDERMAN, N. B.; Exercise and NIDDM (technical review). Diabetes Care, v. 13, p. 785-9, 1990.
51. SHIVA M. et al. Western-Type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemica mice in wich similar plasma cholesterol levels are archieved by a fructoserich diet. Arteriosclerosis, Thrombosis and vascular Biology, v. 19, p. 1223-1230, 1999.
52. TAKAGAWA, Y. et al. Long-termfructose feeding impairs vascular relaxation in rat mesenteric arteries. American Journal of Hypertension, v. 14, p. 811-7, 2001. http://dx.doi.org/S0895-7061(01) 01298-5. (Pubitemid 32682250)
53. UENO, T. et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. Journal of Hepatology, v. 27, p. 103-107, 1997. (Pubitemid 27357062)
54. WAKAME, K. Protective Effects of Active Hexose Correlated Compound (AHCC) on the Onset of Diabetes Induced by Streptozotocin in the Rat. Biomedical Research v. 20, n. 3, p. 145-152, 1999 (Pubitemid 29431473)
55. YAMINI, S. et al. Effect of dietary carbohydrate on liver and kidney enzyme-activities and plasma amino-acids in the la/n-cp rat. International Journal Of Obesity, v. 15, n. 3, p. 189-203, 1991
56. ZAVARONI, I.; BONORA, E.; PAGLIARA, M. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucosa tolerance. New England Journal of Medicine, v. 320, p702-706, 1989. (Pubitemid 19072489)
57. ZECHHIN, H. G.; CARVALHEIRA, J. B. C.; SAAD, M. J. A. Mecanismos moleculares da resistência à insulina na síndrome metabólica. Revista da Sociedade de Cardiologia do Estado de São Paulo v. 14, p. 574-89, 2004. http://dx.doi.org/10.1590/S0004-27302006000200022.